Medline earnings were $693.0M for the trailing 12 months ending Jun 27, 2026, with N/A growth year over year. The latest MDLN earnings report on Jun 27, 2026 announced Q2 2026 earnings of $60.0M, down 53.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MDLN reported annual earnings of $1.2B, with Infinity% growth. The next MDLN earnings date is Nov 4, 2026.
On MDLN's earnings call on Aug 5, 2026, Medline (NASDAQ: MDLN) reported Q2 2026 earnings per share (EPS) of $0.07, up N/A year over year. Total MDLN earnings for the quarter were $60.00 million. In the same quarter last year, Medline's earnings per share (EPS) was N/A.
The next MDLN earnings call is Nov 4, 2026. Add MDLN to your watchlist to be reminded of Medline's next earnings date.
Is Medline profitable or losing money?
As of the last Medline earnings report, Medline is currently profitable. Medline's net profit (also called net income) for the twelve months ending Jun 27, 2026 was $693.00 million, a 919.12% increase year over year.
What was MDLN's earnings growth in the past year?
As of Medline's earnings date in Aug 5, 2026, Medline's earnings has grown year over year. MDLN earnings in the past year totalled $693.00 million.
What are Medline's earnings expectations?
The current EPS estimate for Medline's earnings report in Nov 4, 2026 is $0.32.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.